PRUIX (PRUIX) Stock Price & Analysis
PRUIX (PRUIX) rose 0.06% to USD 192.46 as of July 25, 2026 at 21:13 UTC, according to Nexqual real-time market data.
PRUIX last closed at USD 192.35; the session ranged USD 192.46–192.46 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 164.16–197.83 (NAS). Source: Nexqual, July 25, 2026 at 21:13 UTC.
Key Statistics (as of July 25, 2026 at 21:13 UTC)
| Price | USD 192.46 |
|---|---|
| Change | ▲ 0.06% (up) |
| Previous Close | USD 192.35 |
| Open | USD 192.46 |
| Day Range | USD 192.46 – 192.46 |
| 52-Week Range | USD 164.16 – 197.83 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRUIX)
Nexqual's technical model rates PRUIX "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 21:13 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.5 (neutral) |
| vs SMA50 | Below (USD 194.15) |
| MACD | 0.05 (positive) |
Financial Health Score (PRUIX)
Nexqual rates PRUIX's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 21:13 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRAIX | T. Rowe Price Capital Appreciat | USD 37.77 | ▼ 0.74% |
| PDGIX | T. Rowe Price Dividend Growth F | USD 89.94 | ▲ 0.66% |
| RPTIX | T. Rowe Price Mid-Cap Growth Fu | USD 98.95 | ▼ 0.52% |
| THISX | T. Rowe Price Health Sciences F | USD 90.58 | ▲ 1.27% |
| TTMIX | T. Rowe Price Communications & | USD 124.63 | ▼ 3.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 21:13 UTC. This page is informational and not investment advice.